Online CME: Imaging Renal Cell Carcinoma With Ultrasonography, CT and MRI


This CME activity highlights the techniques, advantages, and limitations of ultrasongraphy, CT, and MRI in evaluating renal masses.

Credits: 1.25Fee: NoneExpires: May 26, 2011

This CME activity, intended for primary care physicians, urologists, nephrologists, oncologists, radiologists, and other physicians who care for patients with renal masses, dovetails with the increased use of abdominal imaging techniques for a variety of indications and the consequent more frequent detection of renal cell carcinoma.

The review will highlight the techniques, advantages, and limitations of ultrasonography, computed tomography (CT), and magnetic resonance imaging (MRI) in the evaluation of renal masses. It will also address the role of these imaging modalities in disease staging, as well as in surveillance of small masses and patients undergoing systemic therapy for advanced RCC.

Click here to access this third-party resource.

Recent Videos
A panel of 5 experts on iron deficiency anemia
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
1 KOL is featured in this series.
1 KOL is featured in this series.
1 KOL is featured in this series.
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Phase 2 Data Shows KP1077 Meaningfully Improves Idiopathic Hypersomnia Symptoms
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
1 KOL is featured in this Insights series.
© 2024 MJH Life Sciences

All rights reserved.